Late-Breaking Science in Thursday's Main Event
Five Late-Breaking Science trials will be reported on during this Main Event.
11 a.m.-12:30 p.m. | Thursday, Feb. 6 | Main Event Hall
LB16 | TRANScranial Direct Current Stimulation for Post-Stroke Motor Recovery: A Phase 2 Study (TRANSPORT2) Main Results
Wayne Feng, Duke University School of Medicine, Chapel Hill, North Carolina
LB17 | Intensive Blood Pressure Lowering After Thrombectomy in Ischemic Stroke Patients: A Randomized Clinical Trial
Xuening Zhang, West China Hospital, Chendu, China
LB18 | Coordinated, Collaborative, Comprehensive, Family-Based, Integrated, Technology-Enabled Post-Stroke Care
George Howard, University of Alabama-Birmingham, Birmingham, Alabama
LB19 | The Intracerebral Hemorrhage Acutely Decreasing Arterial Pressure Trial 2 Final Results
Ken Butcher, University of New South Wales, Randwick, NSW, Australia
LB20 | Atorvastatin Treatment and Rebleeding in Cerebral Cavernous Malformations: A Randomized, Placebo-Controlled, Double-Blinded Clinical Trial
Issam A. Awad, University of Chicago Medical Center, Chicago, Illinois
See Online Program Planner for more information.
